The indications for factor Xa inhibitor therapy were non-valvular atrial fibrillation, including paroxysmal cases, in 62 patients; deep vein thrombosis or pulmonary embolism in 14; and both conditions in 8. The gene discussed is F10; the disease is pulmonary embolism.